Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis

BACKGROUND: Warfarin is traditionally the drug of choice for stroke prophylaxis or treatment of venous thromboembolism in patients with end-stage renal disease (ESRD) on hemodialysis as data on apixaban use is scarce. We aimed to assess the safety and efficacy of Apixaban in patients with ESRD on he...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Indian Pacing Electrophysiol J
Hlavní autoři: Murtaza, Ghulam, Turagam, Mohit K., Garg, Jalaj, Boda, Urooge, Akella, Krishna, Velagapudi, Poonam, Natale, Andrea, Gopinathannair, Rakesh, Lakkireddy, Dhanunjaya
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8263313/
https://ncbi.nlm.nih.gov/pubmed/33866017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ipej.2021.04.002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky